Información del artículo
El Texto completo está disponible en PDF
References
[1.]
A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, M. Zwahlen.
Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
Lancet, 371 (2008), pp. 569-578
[2.]
K.D. Hopkins, D.E. Lehman.
Successful medical treatment of obesity in 10th century Spain.
Lancet, 346 (1995), pp. 452
[3.]
Division of Metabolic and Endocrine Drug Products, Food and Drug Administration. Guidance for the clinical evaluation of weight-control drugs, 1997.
[4.]
L. Abenhain, Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, et al.
Appetite-suppressant drugs and the risk of primary pulmonary hypertension.
New Eng J Med, 335 (1996), pp. 609-616
[5.]
H.M. Conolly, J.L. Crary, M.D. McGoon, D.D. Hensrud, B.S. Edwards, W.D. Edwards, et al.
Valvular heart disease associated with fenfluramine-phentermine.
New Eng J Med, 337 (1997), pp. 581-588
[6.]
F.J. C-Soriguer, F.J. Tinahones.
Principio de precaución y tratamiento con fármacos de las personas obesas.
Med Clin (Barc), 112 (1999), pp. 503-507
[7.]
W.P. James, A. Astrup, N. Finer, J. Hilsted, P. Kopelman, S. Rössner, STORM Study Group, et al.
Sibutramine Trial of Obesity Reduction and Maintenance. Effect of sibutramine on weight maintenance after weight loss: a randomised trial.
Lancet, 356 (2000), pp. 2119-2125
[8.]
W.P.T. James.
The SCOUT study: risk benefit profile of sibutramine in overweight high-risk cardiovascular patients.
Eur Heart J Suppl, 7 (2005), pp. L44-L48
[9.]
L. Sjostrom, K. Narbro, C.D. Sjostrom, K. Karason, B. Larsson, H. Wedel, et al.
Effects of bariatric surgery on mortality in Swedish obese subjects.
N Engl J Med, 357 (2007), pp. 741-752
[10.]
A. Astrup, S. Rössner, L. Van Gaal, A. Rissanen, L. Niskanen, M. Al Hakim, et al.
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
Lancet, 374 (2009), pp. 1606-1616
[11.]
P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, J.I. Gordon.
An obesity-associated gut microbiome with increased capacity for energy harvest.
Nature, 444 (2006), pp. 1027-1031
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
